APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

BACKGROUND: The APOE genotype predicts the age at onset of Alzheimer disease (AD) and neuropathologic progression. However, studies relating APOE alleles to the rate of cognitive decline have been inconclusive. This may stem from their use of linear statistical analyses. OBJECTIVE: To model relation...

Bibliografiset tiedot
Päätekijät:	Martins, C, Oulhaj, A, de Jager, C, Williams, J
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2005

Samankaltaisia teoksia

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Tekijä: Oulhaj, A, et al.
Julkaistu: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Tekijä: Oulhaj, A, et al.
Julkaistu: (2010)

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele
Tekijä: Marian Shahid, et al.
Julkaistu: (2019-07-01)

Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
Tekijä: Haixu Ma, et al.
Julkaistu: (2024-04-01)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
Tekijä: Laura B Zahodne, et al.
Julkaistu: (2013-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
Tekijä: B.V.P. de-Almada, et al.
Julkaistu: (2012-01-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
Tekijä: Kazushi Suzuki, et al.
Julkaistu: (2020-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
Tekijä: B.V.P. de-Almada, et al.
Julkaistu: (2012-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Tekijä: Oulhaj, A, et al.
Julkaistu: (2016)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Tekijä: Holmes, C, et al.
Julkaistu: (2005)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
Tekijä: Jori Tomassen, et al.
Julkaistu: (2022-12-01)

Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
Tekijä: Coralie Barbe, et al.
Julkaistu: (2016-12-01)

Periodontitis and Cognitive Decline in Alzheimer's Disease.
Tekijä: Mark Ide, et al.
Julkaistu: (2016-01-01)

Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease
Tekijä: Céline H. De Jager, et al.
Julkaistu: (2021-02-01)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
Tekijä: Allen, G, et al.
Julkaistu: (2016)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
Tekijä: I. K. Malashenkova, et al.
Julkaistu: (2018-06-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Tekijä: Pia Kivisäkk, et al.
Julkaistu: (2023-03-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Tekijä: Hákon Valur Dansson, et al.
Julkaistu: (2021-09-01)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
Tekijä: Lai, M, et al.
Julkaistu: (2002)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
Tekijä: Nicholas C. Cullen, et al.
Julkaistu: (2021-06-01)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
Tekijä: Lai, M, et al.
Julkaistu: (2006)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
Tekijä: Lai, M, et al.
Julkaistu: (2006)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
Tekijä: Selma M. Soyal, et al.
Julkaistu: (2020-08-01)

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment
Tekijä: Mana Shams, et al.
Julkaistu: (2022-07-01)

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
Tekijä: Sungyang Jo, et al.
Julkaistu: (2021-04-01)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
Tekijä: Yury Loika, et al.
Julkaistu: (2024-10-01)

Rates of decline in Alzheimer disease decrease with age.
Tekijä: Dominic Holland, et al.
Julkaistu: (2012-01-01)

Predicting cognitive decline in healthy older adults.
Tekijä: De Jager, C, et al.
Julkaistu: (2005)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Tekijä: Belbin, O, et al.
Julkaistu: (2009)

Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample
Tekijä: Xiaoran Liu, et al.
Julkaistu: (2024-05-01)

Effect of APOE and CD33 on Cognitive Decline.
Tekijä: Kathleen M Hayden, et al.
Julkaistu: (2015-01-01)

Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Tekijä: Heather E. Dark, et al.
Julkaistu: (2024-04-01)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
Tekijä: Joseph Giorgio, et al.
Julkaistu: (2020-01-01)

Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease
Tekijä: Mitchell K.P. Lai, et al.
Julkaistu: (2006-06-01)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Tekijä: Taizen Nakase, et al.
Julkaistu: (2023-01-01)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
Tekijä: Jagan A. Pillai, et al.
Julkaistu: (2023-03-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
Tekijä: Corinna M. Bauer, et al.
Julkaistu: (2018-02-01)

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
Tekijä: Florian U. Fischer, et al.
Julkaistu: (2021-02-01)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
Tekijä: Jagan A. Pillai, et al.
Julkaistu: (2020-07-01)

Correction: Effect of APOE and CD33 on Cognitive Decline.
Tekijä: Kathleen M Hayden, et al.
Julkaistu: (2015-01-01)